PA008041.m2cLA: In Vivo Grade Recombinant Anti-mouse/human PD-L1 / VEGFR-2 Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone Ate / DC101)
The in vivo grade recombinant anti-mouse/human PD-L1 / VEGFR-2 bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA008040.m2cLA: In Vivo Grade Recombinant Anti-mouse/human PD-L1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone Ate / G6-31)
The in vivo grade recombinant anti-mouse/human PD-L1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA008038.m2cLA: In Vivo Grade Recombinant Anti-mouse/human PD-L1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone Ate / B20-4.1.1.1)
The in vivo grade recombinant anti-mouse/human PD-L1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA008039.m2cLA: In Vivo Grade Recombinant Anti-mouse/human PD-L1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone Ate / G6-23)
The in vivo grade recombinant anti-mouse/human PD-L1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA007510.m1: In vivo Grade Recombinant Anti-human CD19 Monoclonal Antibody, Mouse IgG1 Kappa (Clone: 4G7)
Recombinant mouse IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: 4G7) specifically binds to the human CD19 protein.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human CD19 protein.C026P: Nivolumab Biosimilar, PD-1 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The research grade nivolumab biosimilar specifically binds to PD-1, antagonizing its interaction with its known ligands PD-L1 and PD-L2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by nivolumab.C025P: Durvalumab Biosimilar, PD-L1 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade durvalumab biosimilar specifically binds to the human programmed cell death ligand 1 (PD-L1), blocking its interaction with PD-1 and B7-1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by durvalumab.C029P: Cemiplimab Biosimilar, PD-1 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade cemiplimab biosimilar specifically binds to the programmed cell death protein 1 (PD-1), antagonizing its interaction with its known ligands PD-L1 and PD-L2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by cemiplimab.C023P: Avelumab Biosimilar, PD-L1 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade avelumab biosimilar specifically binds to the programmed death ligand 1 (PD-L1), blocking its interaction with PD-1 and B7-1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by avelumab.C024P: Atezolizumab Biosimilar, PD-L1 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade atezolizumab biosimilar specifically binds to the human PDL1 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by atezolizumab.